Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
Sainas S, Pippione AC, Lupino E, Giorgis M, Circosta P, Gaidano V, Goyal P, Bonanni D, Rolando B, Cignetti A, Ducime A, Andersson M, Järvå M, Friemann R, Piccinini M, Ramondetti C, Buccinnà B, Al-Karadaghi S, Boschi D, Saglio G, Lolli ML.
Sainas S, et al. Among authors: rolando b.
J Med Chem. 2019 Feb 14;62(3):1696. doi: 10.1021/acs.jmedchem.9b00057. Epub 2019 Jan 29.
J Med Chem. 2019.
PMID: 30694669
No abstract available.